Analyst Ratings for Bausch Health Companies (BHC)
BHC Rating Summary
BHC Price Target Summary
- Highest: $7.00 (Barclays)
- Lowest: $7.00 (Barclays)
- Average: $7.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.00 (+30.1%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$7.00 (+30.1%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays » Updated 2/25/2026 |
Glen Santangelo | New Coverage | Equalweight (N/A) |
7.00 (8.00) |
6.93 (5.38) |
-22.37% | Details |
| 2/6/2025 | Jefferies | Glen Santangelo | Downgrade | Hold (Buy) |
8.00 (12.00) |
7.34 (5.38) |
-26.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
